MRPS7 and non-small cell lung carcinoma: Unlike other MRPs, MRP7 was capable of conferring resistance to taxanes [9], and was demonstrated to be used as a predictive marker of resistance to paclitaxel in non-small cell lung cancer (NSCLC) [11].